BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10628406)

  • 1. Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen.
    Leinonen J; Zhang WM; Paus E; Stenman UH
    Tumour Biol; 1999; 20 Suppl 1():28-34. PubMed ID: 10628406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of antibodies to prostate-specific antigen.
    Nilsson O; Andersson I; Peter A; Karlsson B
    Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological grouping of 53 antibodies against prostate-specific antigen.
    Slota J; Lauren L; Rapp J; Dowell B
    Tumour Biol; 1999; 20 Suppl 1():70-4. PubMed ID: 10628411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen.
    Jette DC; Kreutz FT; Suresh MR
    Tumour Biol; 1999; 20 Suppl 1():24-7. PubMed ID: 10628405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen.
    Paus E; Nustad K; Børmer OP
    Tumour Biol; 1999; 20 Suppl 1():52-69. PubMed ID: 10628410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of 53 antibodies against prostate-specific antigen.
    Bellanger L; Andrès C; Seguin P
    Tumour Biol; 1999; 20 Suppl 1():18-23. PubMed ID: 10628404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
    Becker C; Wigheden I; Lilja H
    Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin.
    Chen Z; Chen H; Stamey TA
    J Urol; 1998 Sep; 160(3 Pt 1):870-5. PubMed ID: 9720579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
    Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
    Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
    Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
    Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen.
    Matsumoto K; Konishi N; Samori T; Kimura E; Doi M; Kato S; Yuki Y
    J Immunol Methods; 2000 Feb; 234(1-2):99-106. PubMed ID: 10669774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2.
    Leinonen J; Leinimaa M; Zhang WM; Piironen T; Pettersson K; Lilja H; Dowell B; Stenman UH
    Tumour Biol; 1999; 20 Suppl 1():35-7. PubMed ID: 10628407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro.
    Zhang WM; Leinonen J; Kalkkinen N; Stenman UH
    Prostate; 1997 Oct; 33(2):87-96. PubMed ID: 9316649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS; Xu YA; Ware JH; Kennedy AR
    Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2.
    Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL
    Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex formation between PSA isoenzymes and protease inhibitors.
    Leinonen J; Zhang WM; Stenman UH
    J Urol; 1996 Mar; 155(3):1099-103. PubMed ID: 8583572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.
    Pettersson K; Piironen T; Seppälä M; Liukkonen L; Christensson A; Matikainen MT; Suonpää M; Lövgren T; Lilja H
    Clin Chem; 1995 Oct; 41(10):1480-8. PubMed ID: 7586521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of monoclonal antibodies to prostate-specific antigen: reactivity with native and recombinant prostate-specific antigen.
    Zhou Z; Barnett TR; Very DL; Ng PC; Pellegrino CM; Davis G; Belenky A; Allard WJ; Yeung KK
    Tumour Biol; 1999; 20 Suppl 1():86-93. PubMed ID: 10628414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.
    Lilja H; Christensson A; Dahlén U; Matikainen MT; Nilsson O; Pettersson K; Lövgren T
    Clin Chem; 1991 Sep; 37(9):1618-25. PubMed ID: 1716536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen.
    Stenman UH; Paus E; Allard WJ; Andersson I; Andrès C; Barnett TR; Becker C; Belenky A; Bellanger L; Pellegrino CM; Børmer OP; Davis G; Dowell B; Grauer LS; Jette DC; Karlsson B; Kreutz FT; van der Kwast TM; Lauren L; Leinimaa M; Leinonen J; Lilja H; Linton HJ; Nap M; Hilgers J
    Tumour Biol; 1999; 20 Suppl 1():1-12. PubMed ID: 10628402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.